We will be attending Biotech Showcase in San Francisco from January 7th – 9th.
Now in its 11th year, Biotech Showcase has grown to be one of the largest and most important biotech investor conferences in the world. The event, held at the Hilton San Francisco Union Square, brings more than 3,600 decision makers from 2,200 biotech, financial, and pharma companies to network and share insights on industry trends.
This year’s agenda includes a focus on six therapeutic areas that are seeing intriguing research, innovative technologies, and the promise of transforming the way diseases are treated across the globe:
- Alzheimer’s Disease
- Cell and Gene Therapy
- NASH (Nonalcoholic steatohepatitis)
- Rare and Orphan Diseases
- RNA – The year of RNA and the start of a new era
Random42 Corporate Strategy Director, Richard Grethe, and Chief Sales Officer, Louise Armstrong, will be in attendance if you would like to meet to discuss our capabilities or how we might be able to help you. Please contact us at [email protected] to arrange a meeting.
For more information about Biotech Showcase please visit their website: https://ebdgroup.knect365.com/biotech-showcase/